NCT03941340View on ClinicalTrials.gov

Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 8, 2019

Primary Completion Date

September 6, 2019

Study Completion Date

September 6, 2019

Conditions
Healthy Male Volunteers
Interventions
DRUG

[14]-AST2818

Volunteer will receive a single oral dose of 80 mg /100 u Ci \[14C\]-AST2818 as a solution on Day 1

Trial Locations (1)

215000

First Affiliated Hospital of Soochow University, Suzhou

Sponsors
All Listed Sponsors
lead

Allist Pharmaceuticals, Inc.

INDUSTRY

NCT03941340 - Study Evaluating the Mass Balance And Biotransformation of Single Dose[14C] AST2818 in Chinese Healthy Male Volunteers | Biotech Hunter | Biotech Hunter